{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:40:03Z","timestamp":1795041603993,"version":"4.10.2"},"reference-count":97,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:p>Regulatory B cells (Breg) modulate the immune response in diverse disease settings including transplantation. Despite the lack of a specific phenotypic marker or transcription factor, their significance in transplantation is underscored by their ability to prolong experimental allograft survival, the possibility for their clinical use as immune monitoring tools, and the exciting prospect for them to form the basis for cell therapy. Interleukin (IL)-10 expression remains the most widely used marker for Breg. Several Breg subsets with distinct phenotypes that express this \u201csignature Breg cytokine\u201d have been described in mice and humans. Although T-cell immunoglobulin and mucin family-1 is the most inclusive and functional marker that accounts for murine Breg with disparate mechanisms of action, the significance of T-cell immunoglobulin and mucin family-1 as a marker for Breg in humans still needs to be explored. Although the primary focus of this review is the role of Breg in clinical transplantation, the net modulatory effect of B cells on the immune response and clinical outcomes is the result of the balancing functions of both Breg and effector B cells. Supporting this notion, B-cell IL-10\/tumor necrosis factor \u03b1 ratio is shown to predict immunologic reactivity and clinical outcomes in kidney and liver transplantation. Assessment of Breg:B effector balance using their IL-10\/tumor necrosis factor \u03b1 ratio may identify patients that require more immunosuppression and provide mechanistic insights into potential therapies. In summary, current advances in our understanding of murine and human Breg will pave way for future definitive clinical studies aiming to test them for immune monitoring and as therapeutic targets.<\/jats:p>","DOI":"10.1097\/tp.0000000000004798","type":"journal-article","created":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T04:03:03Z","timestamp":1696219383000},"page":"1080-1089","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Regulatory B Cells in Solid Organ Transplantation: From Immune Monitoring to Immunotherapy"],"prefix":"10.1097","volume":"108","author":[{"given":"Charbel","family":"Elias","sequence":"first","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuxiao","family":"Chen","sequence":"additional","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA."},{"name":"Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind","family":"Cherukuri","sequence":"additional","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA."},{"name":"Renal and Electrolyte Division, Department of Internal Medicine, University of Pittsburgh, Pittsburgh, PA."},{"name":"Department of Immunology, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10,2]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1172\/JCI46274","article-title":"Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice.","volume":"121","author":"Ding","year":"2011","journal-title":"J Clin Invest"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10.","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat Immunol"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/82717","article-title":"Reciprocal regulation of polarized cytokine production by effector B and T cells.","volume":"1","author":"Harris","year":"2000","journal-title":"Nat Immunol"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.4049\/jimmunol.1201427","article-title":"Regulatory B cell (B10 cell) expansion during Listeria infection governs innate and cellular immune responses in mice.","volume":"190","author":"Horikawa","year":"2013","journal-title":"J Immunol"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"7741","DOI":"10.1158\/0008-5472.CAN-05-3766","article-title":"Inhibitory effects of B cells on antitumor immunity.","volume":"66","author":"Inoue","year":"2006","journal-title":"Cancer Res"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1158\/0008-5472.CAN-12-3450","article-title":"Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells.","volume":"73","author":"Lindner","year":"2013","journal-title":"Cancer Res"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1084\/jem.20021293","article-title":"Prevention of arthritis by interleukin 10-producing B cells.","volume":"197","author":"Mauri","year":"2003","journal-title":"J Exp Med"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.immuni.2010.10.016","article-title":"Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection.","volume":"33","author":"Neves","year":"2010","journal-title":"Immunity"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","article-title":"A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses.","volume":"28","author":"Yanaba","year":"2008","journal-title":"Immunity"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1074-7613(02)00274-1","article-title":"Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation.","volume":"16","author":"Mizoguchi","year":"2002","journal-title":"Immunity"},{"key":"R12-20250604","first-page":"3420","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression.","volume":"118","author":"Matsushita","year":"2008","journal-title":"J Clin Invest"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.immuni.2016.02.012","article-title":"A regulatory feedback between plasmacytoid dendritic cells and regulatory B Cells is aberrant in systemic lupus erythematosus.","volume":"44","author":"Menon","year":"2016","journal-title":"Immunity"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.4049\/jimmunol.1602107","article-title":"TIM-4 identifies IFN-gamma-expressing proinflammatory B effector 1 cells that promote tumor and allograft rejection.","volume":"199","author":"Ding","year":"2017","journal-title":"J Immunol"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1084\/jem.20111675","article-title":"B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.","volume":"209","author":"Barr","year":"2012","journal-title":"J Exp Med"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nm.3554","article-title":"Interleukin-35 induces regulatory B cells that suppress autoimmune disease.","volume":"20","author":"Wang","year":"2014","journal-title":"Nat Med"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.coi.2008.03.003","article-title":"Cytokine-producing B lymphocytes-key regulators of immunity.","volume":"20","author":"Lund","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","article-title":"Immune regulatory function of B cells.","volume":"30","author":"Mauri","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/imr.12933","article-title":"Regulatory B cells: TIM-1, transplant tolerance, and rejection.","volume":"299","author":"Cherukuri","year":"2021","journal-title":"Immunol Rev"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/MOT.0000000000001010","article-title":"Regulatory and transitional B cells: potential biomarkers and therapeutic targets in organ transplantation.","volume":"27","author":"Cherukuri","year":"2022","journal-title":"Curr Opini Organ Transplant"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/MOT.0000000000000559","article-title":"Regulatory B cells and transplantation: almost prime time?","volume":"23","author":"Mohib","year":"2018","journal-title":"Curr Opin Organ Transplant"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1172\/JCI39922","article-title":"Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans.","volume":"120","author":"Sagoo","year":"2010","journal-title":"J Clin Invest"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1172\/JCI39933","article-title":"Identification of a B cell signature associated with renal transplant tolerance in humans.","volume":"120","author":"Newell","year":"2010","journal-title":"J Clin Invest"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/251550a0","article-title":"B-cell suppression of delayed hypersensitivity reactions.","volume":"251","author":"Katz","year":"1974","journal-title":"Nature"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.184.6.2271","article-title":"Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice.","volume":"184","author":"Wolf","year":"1996","journal-title":"J Exp Med"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.4049\/jimmunol.0803052","article-title":"Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL\/lpr mice.","volume":"182","author":"Blair","year":"2009","journal-title":"J Immunol"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/IAI.70.2.812-819.2002","article-title":"Fas ligand-expressing B-1a lymphocytes mediate CD4(+)-T-cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10.","volume":"70","author":"Lundy","year":"2002","journal-title":"Infect Immun"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1681\/ASN.2014040404","article-title":"Tolerant kidney transplant patients produce B cells with regulatory properties.","volume":"26","author":"Chesneau","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaut.2015.02.004","article-title":"B-cells induce regulatory T cells through TGF-beta\/IDO production in A CTLA-4 dependent manner.","volume":"59","author":"Nouel","year":"2015","journal-title":"J Autoimmun"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1038\/ncomms6997","article-title":"PD-L1hi B cells are critical regulators of humoral immunity.","volume":"6","author":"Khan","year":"2015","journal-title":"Nat Commun"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"107892","DOI":"10.1016\/j.celrep.2020.107892","article-title":"Checkpoint receptor tigit expressed on Tim-1(+) B cells regulates tissue inflammation.","volume":"32","author":"Xiao","year":"2020","journal-title":"Cell reports"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.4049\/jimmunol.178.10.6028","article-title":"Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes.","volume":"178","author":"Deng","year":"2007","journal-title":"J Immunol"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1111\/ajt.16772","article-title":"Properties of regulatory B cells regulating B cell targets.","volume":"21","author":"Fu","year":"2021","journal-title":"Am J Transplant"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"e152213","DOI":"10.1172\/jci.insight.152213","article-title":"Suppression of allograft rejection by regulatory B cells induced via TLR signaling.","volume":"7","author":"Lee","year":"2022","journal-title":"JCI Insight"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/ajt.15546","article-title":"Antigen-dependent interactions between regulatory B cells and T cells at the T:B border inhibit subsequent T cell interactions with DCs.","volume":"20","author":"Mohib","year":"2020","journal-title":"Am J Transplant"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"14080","DOI":"10.1073\/pnas.0700326104","article-title":"Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells.","volume":"104","author":"Gray","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/ajt.13087","article-title":"TIM-1 signaling is required for maintenance and induction of regulatory B cells.","volume":"15","author":"Yeung","year":"2015","journal-title":"Am J Transplant"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"12105","DOI":"10.1073\/pnas.1120914109","article-title":"Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice.","volume":"109","author":"Xiao","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.1402632","article-title":"Tim-1 is essential for induction and maintenance of IL-10 in regulatory B cells and their regulation of tissue inflammation.","volume":"194","author":"Xiao","year":"2015","journal-title":"J Immunol"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/imr.12800","article-title":"Regulatory B cells: development, phenotypes, functions, and role in transplantation.","volume":"292","author":"Alhabbab","year":"2019","journal-title":"Immunol Rev"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"173ra23","DOI":"10.1126\/scitranslmed.3005407","article-title":"CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation.","volume":"5","author":"Flores-Borja","year":"2013","journal-title":"Sci Transl Med"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41467-021-21413-y","article-title":"Implication of TIGIT(+) human memory B cells in immune regulation.","volume":"12","author":"Hasan","year":"2021","journal-title":"Nat Commun"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jaci.2013.01.014","article-title":"IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses.","volume":"131","author":"van de Veen","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.3389\/fimmu.2017.01951","article-title":"Expression of tumor necrosis factor receptor 2 characterizes TLR9-driven formation of interleukin-10-producing B cells.","volume":"8","author":"Ticha","year":"2017","journal-title":"Front Immunol"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2119\/molmed.2012.00203","article-title":"Human \u201corchestrator\u201d CD11b(+) B1 cells spontaneously secrete interleukin-10 and regulate T-cell activity.","volume":"18","author":"Griffin","year":"2012","journal-title":"Mol Med"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.tube.2013.12.003","article-title":"Anti-tuberculosis treatment enhances the production of IL-22 through reducing the frequencies of regulatory B cell.","volume":"94","author":"Zhang","year":"2014","journal-title":"Tuberculosis (Edinb)"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.3389\/fimmu.2018.03034","article-title":"CD9(+) regulatory B cells induce T cell apoptosis via IL-10 and are reduced in severe asthmatic patients.","volume":"9","author":"Brosseau","year":"2018","journal-title":"Front Immunol"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.immuni.2014.10.016","article-title":"Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation.","volume":"41","author":"Matsumoto","year":"2014","journal-title":"Immunity"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"e1082703","DOI":"10.1080\/2162402X.2015.1082703","article-title":"Phenotypic and functional characteristics of CD39(high) human regulatory B cells (Breg).","volume":"5","author":"Figueiro","year":"2016","journal-title":"Oncoimmunology"},{"key":"R51-20250604","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13075-016-1213-9","article-title":"TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients.","volume":"19","author":"Aravena","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"R52-20250604","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s40425-018-0451-6","article-title":"Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1(+) regulatory B cell expansion.","volume":"6","author":"Ye","year":"2018","journal-title":"J ImmunoTher Cancer"},{"key":"R53-20250604","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1038\/s41467-022-30613-z","article-title":"Ex vivo-expanded human CD19(+)TIM-1(+) regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1\/STAT3 axis.","volume":"13","author":"Shankar","year":"2022","journal-title":"Nat Commun"},{"key":"R54-20250604","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1681\/ASN.2013080837","article-title":"Immunologic human renal allograft injury associates with an altered IL-10\/TNF-alpha expression ratio in regulatory B cells.","volume":"25","author":"Cherukuri","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R55-20250604","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.kint.2016.08.028","article-title":"Reduced human transitional B cell T1\/T2 ratio is associated with subsequent deterioration in renal allograft function.","volume":"91","author":"Cherukuri","year":"2017","journal-title":"Kidney Int"},{"key":"R56-20250604","doi-asserted-by":"crossref","first-page":"110728","DOI":"10.1016\/j.celrep.2022.110728","article-title":"Human IL-10-producing B cells have diverse states that are induced from multiple B cell subsets.","volume":"39","author":"Glass","year":"2022","journal-title":"Cell reports"},{"key":"R57-20250604","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1111\/ajt.13904","article-title":"Transcriptomic signature of the CD24(hi) CD38(hi) transitional B cells associated with an immunoregulatory phenotype in renal transplant recipients.","volume":"16","author":"Bigot","year":"2016","journal-title":"Am J Transplant"},{"key":"R58-20250604","doi-asserted-by":"crossref","first-page":"310ra166","DOI":"10.1126\/scitranslmed.aab4176","article-title":"Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy.","volume":"7","author":"Li","year":"2015","journal-title":"Sci Transl Med"},{"key":"R59-20250604","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.21939","article-title":"Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?","volume":"67","author":"Bar-Or","year":"2010","journal-title":"Ann Neurol"},{"key":"R60-20250604","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1056\/NEJMc0808481","article-title":"B-cell-depleting induction therapy and acute cellular rejection.","volume":"360","author":"Clatworthy","year":"2009","journal-title":"N Engl J Med"},{"key":"R61-20250604","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jacc.2019.04.056","article-title":"Accelerated allograft vasculopathy with rituximab after cardiac transplantation.","volume":"74","author":"Starling","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R62-20250604","doi-asserted-by":"crossref","first-page":"15448","DOI":"10.1073\/pnas.0705834104","article-title":"Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance.","volume":"104","author":"Brouard","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R63-20250604","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/archsurg.1975.01360180020004","article-title":"Discontinuance of immunosuprression in renal transplant patients.","volume":"110","author":"Owens","year":"1975","journal-title":"Arch Surg"},{"key":"R64-20250604","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1111\/j.1600-6143.2012.04249.x","article-title":"The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases.","volume":"12","author":"Brouard","year":"2012","journal-title":"Am J Transplant"},{"key":"R65-20250604","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1111\/ajt.13932","article-title":"Biomarkers of tolerance in kidney transplantation: are we predicting tolerance or response to immunosuppressive treatment?","volume":"16","author":"Rebollo-Mesa","year":"2016","journal-title":"Am J Transplant"},{"key":"R66-20250604","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1097\/TXD.0000000000000638","article-title":"Application of operational tolerance signatures are limited by variability and type of immunosuppression in renal transplant recipients: a cross-sectional study.","volume":"3","author":"Bottomley","year":"2017","journal-title":"Transplant Direct"},{"key":"R67-20250604","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1111\/ajt.13480","article-title":"Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients.","volume":"15","author":"Newell","year":"2015","journal-title":"Am J Transplant"},{"key":"R68-20250604","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1111\/j.1600-6143.2011.03638.x","article-title":"Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients.","volume":"11","author":"Lozano","year":"2011","journal-title":"Am J Transplant"},{"key":"R69-20250604","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/TP.0b013e3182789a24","article-title":"B-cell-related biomarkers of tolerance are up-regulated in rejection-free kidney transplant recipients.","volume":"95","author":"Viklicky","year":"2013","journal-title":"Transplantation"},{"key":"R70-20250604","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1097\/TP.0000000000000465","article-title":"B cell markers of operational tolerance can discriminate acute kidney allograft rejection from stable graft function.","volume":"99","author":"Heidt","year":"2015","journal-title":"Transplantation"},{"key":"R71-20250604","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1600-6143.2011.03891.x","article-title":"An analysis of lymphocyte phenotype after steroid avoidance with either alemtuzumab or basiliximab induction in renal transplantation.","volume":"12","author":"Cherukuri","year":"2012","journal-title":"Am J Transplant"},{"key":"R72-20250604","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/ajt.13122","article-title":"Transitional B lymphocytes are associated with protection from kidney allograft rejection: a prospective study.","volume":"15","author":"Shabir","year":"2015","journal-title":"Am J Transplant"},{"key":"R73-20250604","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/tri.12751","article-title":"Dynamic changes of B-cell compartments in kidney transplantation: lack of transitional B cells is associated with allograft rejection.","volume":"29","author":"Svachova","year":"2016","journal-title":"Transpl Int"},{"key":"R74-20250604","doi-asserted-by":"crossref","first-page":"101245","DOI":"10.1016\/j.trim.2019.101245","article-title":"Peripheral CD19+CD24(high)CD38(high) B-regulatory cells in lung transplant recipients.","volume":"57","author":"Piloni","year":"2019","journal-title":"Transpl Immunol"},{"key":"R75-20250604","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1111\/ajt.15532","article-title":"Blood CD9(+) B cell, a biomarker of bronchiolitis obliterans syndrome after lung transplantation.","volume":"19","author":"Brosseau","year":"2019","journal-title":"Am J Transplant"},{"key":"R76-20250604","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/ki.2015.100","article-title":"B-lymphocytes support and regulate indirect T-cell alloreactivity in individual patients with chronic antibody-mediated rejection.","volume":"88","author":"Shiu","year":"2015","journal-title":"Kidney Int"},{"key":"R77-20250604","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.kint.2016.10.009","article-title":"Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell-dependent indirect antidonor alloresponses and autocrine regulation of interferon-gamma production by Th1 cells.","volume":"91","author":"Shiu","year":"2017","journal-title":"Kidney Int"},{"key":"R78-20250604","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fimmu.2020.00079","article-title":"Effect of optimized immunosuppression (including rituximab) on anti-donor alloresponses in patients with chronically rejecting renal allografts.","volume":"11","author":"Shiu","year":"2020","journal-title":"Front Immunol"},{"key":"R79-20250604","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12882-021-02374-2","article-title":"Higher CD19+CD25(+) Bregs are independently associated with better graft function in renal transplant recipients.","volume":"22","author":"Ibrahim","year":"2021","journal-title":"BMC Nephrol"},{"key":"R80-20250604","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1182\/blood-2016-01-695122","article-title":"IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation.","volume":"128","author":"Sarvaria","year":"2016","journal-title":"Blood"},{"key":"R81-20250604","doi-asserted-by":"crossref","first-page":"465","DOI":"10.21037\/atm.2019.08.05","article-title":"The proportion of CD19(+)CD24(hi)CD27(+) regulatory B cells predicts the occurrence of acute allograft rejection in liver transplantation.","volume":"7","author":"Zhou","year":"2019","journal-title":"Ann Transl Med"},{"key":"R82-20250604","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.kint.2022.04.040","article-title":"Antigen-specific B cells in kidney transplantation.","volume":"102","author":"Bou Saba","year":"2022","journal-title":"Kidney Int"},{"key":"R83-20250604","doi-asserted-by":"crossref","first-page":"eabe4929","DOI":"10.1126\/scitranslmed.abe4929","article-title":"Transitional B cell cytokines predict renal allograft outcomes.","volume":"13","author":"Cherukuri","year":"2021","journal-title":"Sci Transl Med"},{"key":"R84-20250604","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.kint.2022.10.026","article-title":"Transitional B cell cytokines risk stratify early borderline rejection after renal transplantation.","volume":"103","author":"Cherukuri","year":"2023","journal-title":"Clinical Invest Kidney Int"},{"key":"R85-20250604","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.humimm.2023.03.003","article-title":"IL-10-producing memory B regulatory cells as a novel target for HLA-G to prolong human kidney allograft survival.","volume":"84","author":"Ajith","year":"2023","journal-title":"Hum Immunol"},{"key":"R86-20250604","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.4049\/jimmunol.2000335","article-title":"Efficient expansion of human granzyme b-expressing B cells with potent regulatory properties.","volume":"205","author":"Chesneau","year":"2020","journal-title":"J Immunol"},{"key":"R87-20250604","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.clim.2017.05.012","article-title":"Regulatory B cells in rheumatoid arthritis: alterations in patients receiving anti-TNF therapy.","volume":"184","author":"Banko","year":"2017","journal-title":"Clin Immunol"},{"key":"R88-20250604","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/ajt.16283","article-title":"Rejection of intestinal allotransplants is driven by memory T helper type 17 immunity and responds to infliximab.","volume":"21","author":"Kroemer","year":"2021","journal-title":"Am J Transplant"},{"key":"R89-20250604","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1111\/j.1600-6143.2012.04012.x","article-title":"B cell repopulation after alemtuzumab induction-transient increase in transitional B cells and long-term dominance of naive B cells.","volume":"12","author":"Heidt","year":"2012","journal-title":"Am J Transplant"},{"key":"R90-20250604","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/ajt.12721","article-title":"Kidney transplant recipients treated with belatacept exhibit increased naive and transitional B cells.","volume":"14","author":"Leibler","year":"2014","journal-title":"Am J Transplant"},{"key":"R91-20250604","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/ajt.15639","article-title":"B cell reconstitution following alemtuzumab induction under a belatacept-based maintenance regimen.","volume":"20","author":"Xu","year":"2020","journal-title":"Am J Transplant"},{"key":"R92-20250604","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1016\/S0140-6736(18)30984-X","article-title":"Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial.","volume":"391","author":"Banham","year":"2018","journal-title":"Lancet"},{"key":"R93-20250604","first-page":"697","article-title":"Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy.","volume":"29","author":"Snir","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"R94-20250604","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/ajt.16926","article-title":"Clazakizumab for desensitization in highly sensitized patients awaiting transplantation.","volume":"22","author":"Vo","year":"2022","journal-title":"Am J Transplant"},{"key":"R95-20250604","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1681\/ASN.2022040454","article-title":"Infliximab induction lacks efficacy and increases bk virus infection in deceased donor kidney transplant recipients: results of the CTOT-19 trial.","volume":"34","author":"Hricik","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"R96-20250604","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41467-017-02683-x","article-title":"Hypoxia-inducible factor-1alpha is a critical transcription factor for IL-10-producing B cells in autoimmune disease.","volume":"9","author":"Meng","year":"2018","journal-title":"Nat Commun"},{"key":"R97-20250604","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1053\/j.ajkd.2016.12.011","article-title":"Hypoxia-inducible factor prolyl hydroxylase inhibitors: a potential new treatment for anemia in patients with CKD.","volume":"69","author":"Gupta","year":"2017","journal-title":"Am J Kidney Dis"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:07:45Z","timestamp":1749060465000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,2]]},"references-count":97,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004798","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,2]]}}}